| 1 |
Carvalho C, Moreira PI. Metabolic defects shared by Alzheimer's disease and diabetes: A focus on mitochondria. Curr Opin Neurobiol 2023;79:102694. [PMID: 36842275 DOI: 10.1016/j.conb.2023.102694] [Reference Citation Analysis]
|
| 2 |
Li Y, Li M, Zhao K, Wang Y, Tan X, Qin C, Rao Y, Sun Z, Ge L, Cao Z, Liang Y, Qiu S. Altered dynamic functional architecture in type 2 diabetes mellitus. Front Endocrinol (Lausanne) 2022;13:1117735. [PMID: 36760808 DOI: 10.3389/fendo.2022.1117735] [Reference Citation Analysis]
|
| 3 |
Kodishala C, Hulshizer CA, Kronzer VL, Davis JM 3rd, Ramanan VK, Vassilaki M, Mielke MM, Crowson CS, Myasoedova E. Risk Factors for Dementia in Patients With Incident Rheumatoid Arthritis: A Population-Based Cohort Study. J Rheumatol 2023;50:48-55. [PMID: 35840149 DOI: 10.3899/jrheum.220200] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 4 |
Ferrari F, Moretti A, Villa RF. Incretin-based drugs as potential therapy for neurodegenerative diseases: current status and perspectives. Pharmacology & Therapeutics 2022;239:108277. [DOI: 10.1016/j.pharmthera.2022.108277] [Reference Citation Analysis]
|
| 5 |
Canna A, Esposito F, Tedeschi G, Trojsi F, Passaniti C, di Meo I, Polito R, Maiorino MI, Paolisso G, Cirillo M, Rizzo MR. Neurovascular coupling in patients with type 2 diabetes mellitus. Front Aging Neurosci 2022;14:976340. [DOI: 10.3389/fnagi.2022.976340] [Reference Citation Analysis]
|
| 6 |
Kumar V, Kim S, Bishayee K. Dysfunctional Glucose Metabolism in Alzheimer’s Disease Onset and Potential Pharmacological Interventions. IJMS 2022;23:9540. [DOI: 10.3390/ijms23179540] [Reference Citation Analysis]
|
| 7 |
Lai MC, Liu WY, Liou SS, Liu IM. Diosmetin Targeted at Peroxisome Proliferator-Activated Receptor Gamma Alleviates Advanced Glycation End Products Induced Neuronal Injury. Nutrients 2022;14:2248. [PMID: 35684047 DOI: 10.3390/nu14112248] [Reference Citation Analysis]
|
| 8 |
Cimini FA, Perluigi M, Barchetta I, Cavallo MG, Barone E. Role of Biliverdin Reductase A in the Regulation of Insulin Signaling in Metabolic and Neurodegenerative Diseases: An Update. Int J Mol Sci 2022;23:5574. [PMID: 35628384 DOI: 10.3390/ijms23105574] [Reference Citation Analysis]
|
